You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRTX Disposition Disclosure
Sussman Joel F. · SEC Form 4 · Filed Aug 5, 2026
Disposition
Reported value range
Not reported
Sussman Joel F. Chief Accounting Officer
GRTX
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
GRTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 10,000 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001193125-26-335196
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galera Therapeutics, Inc. GRTX Current | Disposition | Aug 3, 2026 | Not reported |